Research on Vaccine to Treat Heroin Addiction Faces Funding Challenges

A vaccine to treat heroin addiction has shown promise in rat studies, but faces challenges including a lack of funding, Time reports.

Researcher Kim Janda at the Scripps Research Institute in La Jolla, California, says drug companies are not interested in addiction vaccines. He has been studying treatments for heroin and methamphetamine addiction, as well as cocaine overdoses.

“No pharmaceutical company is going to fund trials for heroin, no way,” Janda said. “For meth? No way. Forget about it.” Janda is most hopeful about the heroin vaccine. “The heroin one has been our best success in over 25 years of working—it’s the best data we’ve seen,” he noted.

Full story of vaccine to treat heroin addiction at drugfree.org

Published by

Will Savage

Quantum Units Continuing Education provides online CEU training's to licensed professional mental health therapists, counselors, social workers and nurses. Our blog provides updates in the field of news and research related to mental health and substance abuse treatment.